HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,879,440 | -21.2% | 49,200 | -25.6% | 0.00% | -25.0% |
| Q2 2023 | $2,384,227 | +45.5% | 66,100 | +54.1% | 0.00% | +33.3% |
| Q1 2023 | $1,638,351 | +16283.5% | 42,900 | +16592.6% | 0.00% | – |
| Q1 2022 | $10,000 | -98.2% | 257 | -98.2% | 0.00% | -100.0% |
| Q4 2021 | $564,000 | +195.3% | 14,030 | +198.8% | 0.00% | – |
| Q3 2021 | $191,000 | +267.3% | 4,695 | +311.5% | 0.00% | – |
| Q2 2021 | $52,000 | -81.8% | 1,141 | -83.0% | 0.00% | – |
| Q4 2020 | $286,000 | -90.8% | 6,700 | -94.2% | 0.00% | -100.0% |
| Q2 2020 | $3,113,000 | +5.1% | 116,100 | -30.5% | 0.01% | +16.7% |
| Q4 2019 | $2,963,000 | +6634.1% | 167,100 | +4674.3% | 0.01% | – |
| Q1 2014 | $44,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |